Frontlight ResearchEarly access
Gastric and oesophageal cancer trials in China
723 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleComparison of Double-tract and Tubular Gastric Anastomosis in Proximal Gastric Cancer
- Where
- Jinan
- Age
- 18 years to 75 years
- People
- 52
- Run by
- Qilu Hospital of Shandong University
See details and how to joinNCT07635836 - Phase 3Not yet taking people in ChinaFeasibility of Circulating Tumor DNA Based Minimal Residual Disease-Guided Adjuvant Therapy in Locally Advanced Gastric Cancer With Neoadjuvant Treatment
- Where
- Shanghai
- Age
- 18 years and over
- People
- 304
- Run by
- Shanghai Zhongshan Hospital
See details and how to joinNCT07508956 - Phase 2Not yet taking people in ChinaA Phase II Study of GV20-0251 in Combination With Anti-PD-1 Monoclonal Antibodies in Patients With Unresectable, Locally Advanced, or Metastatic Solid Tumors.
- Where
- Beijing, Harbin
- Age
- 18 years to 80 years
- People
- 227
- Run by
- GV20 Therapeutics
See details and how to joinNCT07623642 - Phase 2/3Taking peopleTo Evaluate IAH0968 in Combination With CAPEOX in HER2-positive Gastric Cancer
- Where
- Harbin, Shenyang
- Age
- 18 years to 75 years
- People
- 574
- Run by
- SUNHO(China)BioPharmaceutical CO., Ltd.
See details and how to joinNCT06504732 - Phase 2Taking peopleCombination Immunotherapy of Adebrelimab With Apatinib and Tegafur, Gimeracil and Oteracil Potassium Capsules for Immune Rechallenge Therapy in Esophageal Squamous Cell Carcinoma
- Where
- Guangzhou
- Age
- 18 years to 75 years
- People
- 32
- Run by
- Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
See details and how to joinNCT06339619 - Phase 2Taking peopleIBI343 in Combination Therapy for Advanced Malignant Solid Tumors
- Where
- Hangzhou
- Age
- 18 years and over
- People
- 389
- Run by
- Innovent Biologics (Suzhou) Co. Ltd.
See details and how to joinNCT07483554 - Phase 2Taking peopleIBI343 in Combination With Sintilimab and SOX Regimen for Perioperative Treatment of Resectable, Locally Advanced Gastric or Gastroesophageal Junction Adenocarcinoma
- Where
- Beijing
- Age
- 18 years to 75 years
- People
- 90
- Run by
- Innovent Biologics (Suzhou) Co. Ltd.
See details and how to joinNCT07483567 - Phase 2Not yet taking people in ChinaTafolecimab Combined With Sintilimab and SOX in the Treatment of pMMR/MSS Gastric Cancer
- Where
- Hangzhou
- Age
- 18 years to 75 years
- People
- 30
- Run by
- First Affiliated Hospital of Zhejiang University
See details and how to joinNCT07621562 - Phase 2Taking peopleThe Efficacy and Safety of Fosrolapitant and Palonosetron Hydrochloride for Injection in Preventing Nausea and Vomiting Caused by Multi-cycle Immunotherapy and Chemotherapy in Patients With Esophageal Cancer and Lung Cancer
- Where
- Hangzhou
- Age
- 18 years and over
- People
- 120
- Run by
- Second Affiliated Hospital, Zhejiang University, School of Medicine
See details and how to joinNCT07617246 - Phase 2Not yet taking people in ChinaRetlirafusp Alfa Plus Chemotherapy as Neoadjuvant Therapy for Thoracic ESCC
- Where
- Xi'an
- Age
- 18 years to 75 years
- People
- 33
- Run by
- Tang-Du Hospital
See details and how to joinNCT07618910 - No phaseNot yet taking people in ChinaA Study on the Efficacy of Sodium Propionate Combined With Anti-PD-1 Immunotherapy in Gastric Cancer
- Where
- Nanjing
- Age
- 18 years to 80 years
- People
- 20
- Run by
- Jinling Hospital, China
See details and how to joinNCT07615907 - Phase 2Taking peopleTime-of-Day of Immunotherapy Infusion in Neoadjuvant Immunochemotherapy for Thoracic ESCC
- Where
- Xi'an
- Age
- 18 years to 75 years
- People
- 90
- Run by
- Tang-Du Hospital
See details and how to joinNCT07452601 - Phase 2Not yet taking people in ChinaRetlirafusp Alfa Combined With Apatinib and Nab-Paclitaxel as Second-line Treatment for Gastric or Gastroesophageal Junction Cancer
- Where
- Zhengzhou
- Age
- 18 years and over
- People
- 50
- Run by
- Henan Cancer Hospital
See details and how to joinNCT07610629 - Phase 2Not yet taking people in ChinaSKB315 in Combination Therapy in Patients With Advanced or Metastatic GC/ GEJ Adenocarcinoma
- Where
- Beijing
- Age
- 18 years to 80 years
- People
- 80
- Run by
- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
See details and how to joinNCT07609667 - Early phase 1Taking peopleCDH17 CAR-T Therapy in Advanced Malignant Solid Tumors
- Where
- Hangzhou
- Age
- 18 years to 70 years
- People
- 36
- Run by
- Zhejiang University
See details and how to joinNCT06937567 - Phase 2Not yet taking people in ChinaA Clinical Study of SHR-1701 Combined With Chemotherapy for the Perioperative Treatment of Locally Advanced Resectable Siewert Type II Adenocarcinoma of the Esophagogastric Junction
- Where
- Shijiazhuang
- Age
- 18 years to 75 years
- People
- 38
- Run by
- Hebei Medical University Fourth Hospital
See details and how to joinNCT07607210 - Phase 4Enrolling by invitationHematoporphyrin Photodynamic Therapy for Esophageal Cancer
- Where
- Guangzhou
- Age
- 18 years to 80 years
- People
- 198
- Run by
- Sun Yat-sen University
See details and how to joinNCT06437288 - Phase 2/3Not yet taking people in ChinaAdaptive Adjuvant Therapy After Neoadjuvant Therapy and Gastrectomy for Gastric or Gastroesophageal Junction Adenocarcinoma
- Where
- Guangzhou
- Age
- 18 years to 75 years
- People
- 405
- Run by
- Nanfang Hospital, Southern Medical University
See details and how to joinNCT07603349 - Phase 2Taking peopleChemoradiation Plus Iparomlimab Consolidation in Older With ESCC
- Where
- Tianjin
- Age
- 70 years to 90 years
- People
- 52
- Run by
- Tianjin Medical University Cancer Institute and Hospital
See details and how to joinNCT07038629 - Phase 1Taking peopleTo Evaluate the Safety, Tolerability, and Preliminary Efficacy of XH001 Injection as Adjuvant Therapy in Patients With High-risk Recurrent Solid Tumors
- Where
- Beijing
- Age
- 18 years to 70 years
- People
- 48
- Run by
- Shenzhen Xinhe Biomedical
See details and how to joinNCT07594964 - Phase 2Taking peopleAdebrelimab Combined With Neoadjuvant Chemoradiotherapy for Esophageal Squamous Cell Carcinoma
- Where
- Guangzhou
- Age
- 18 years to 75 years
- People
- 37
- Run by
- Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
See details and how to joinNCT07595770 - Phase 2Taking peopleA Phase II Clinical Study to Evaluate HLX43 in Patients With Recurrent/Metastatic ESCC Failed or Intolerance to Standard Therapy
- Where
- Jinan
- Age
- 18 years to 75 years
- People
- 102
- Run by
- Shanghai Henlius Biotech
See details and how to joinNCT06769113 - Phase 1Not yet taking people in ChinaNeoadjuvant SHR-A1811 and SHR-A1701 for Potentially Immunotherapy-Sensitive GC or GEJ Adenocarcinoma
- Where
- Nanjing
- Age
- 18 years to 75 years
- People
- 12
- Run by
- The First Affiliated Hospital with Nanjing Medical University
See details and how to joinNCT07581574 - Phase 2Taking peopleImmune Checkpoint Inhibitors for Organ Preservation in Non-metastatic dMMR/MSI-H Gastric or Colon Cancers
- Where
- Beijing
- Age
- 18 years and over
- People
- 34
- Run by
- Peking University
See details and how to joinNCT06580574 - Phase 3Taking peopleSHR-A1904 Compared With Investigator's Choice of Therapy in Claudin18.2 Positive Patitens With Second-line Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
- Where
- Guangzhou
- Age
- 18 years to 75 years
- People
- 524
- Run by
- Shanghai Hengrui Pharmaceutical Co., Ltd.
See details and how to joinNCT06649292